Home/Filings/4/0001415889-24-008770
4//SEC Filing

Dake Benjamin T 4

Accession 0001415889-24-008770

CIK 0001798749other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 6:00 PM ET

Size

15.0 KB

Accession

0001415889-24-008770

Insider Transaction Report

Form 4
Period: 2024-03-18
Dake Benjamin T
See Remarks
Transactions
  • Sale

    Common Stock

    2024-03-18$25.74/sh27,476$707,2828,872 total
  • Sale

    Common Stock

    2024-03-18$26.48/sh7,581$200,7641,291 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-03-1820,557102,789 total
    Exercise: $2.14Exp: 2031-04-01Common Stock (20,557 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-03-1814,50043,500 total
    Exercise: $10.61Exp: 2031-12-13Common Stock (14,500 underlying)
  • Exercise/Conversion

    Common Stock

    2024-03-18$2.14/sh+20,557$43,99221,848 total
  • Exercise/Conversion

    Common Stock

    2024-03-18$10.61/sh+14,500$153,84536,348 total
Footnotes (5)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.235 to $26.234, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.25 to $26.88, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F4]A total of 328,921 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, and with shares vesting in 48 substantially equal monthly installments.
  • [F5]A total of 58,000 shares subject to an employee stock option were granted on December 14, 2021, with the first installment vested on January 14, 2022, and with shares vesting in 48 substantially equal monthly installments.

Issuer

Aerovate Therapeutics, Inc.

CIK 0001798749

Entity typeother

Related Parties

1
  • filerCIK 0001869248

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 6:00 PM ET
Size
15.0 KB